Last update 17 Jul 2025

PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms-
Target
CDK9
Action
degraders
Mechanism
CDK9 degraders(Cyclin-dependent kinase 9 degraders)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
University of Nebraska Medical CenterUniversity of Nebraska Medical Center
Active Organization-
Inactive Organization
University of Nebraska Medical CenterUniversity of Nebraska Medical Center
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC33H35N5O7
InChIKeyWCEHIDWONYOKOJ-UHFFFAOYSA-N
CAS Registry2118356-96-8

Related

100 Clinical Results associated with PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)
Login to view more data
100 Translational Medicine associated with PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)
Login to view more data
100 Patents (Medical) associated with PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)
Login to view more data
1
Literatures (Medical) associated with PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)
Chemical communications (Cambridge, England)Q2 · CHEMISTRY
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Q2 · CHEMISTRY
100 Deals associated with PROTAC CDK9 Degrader-1(University of Nebraska Medical Center)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
University of Nebraska Medical CenterUniversity of Nebraska Medical Center
04 Jul 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free